1. Home
  2. MOMO vs GERN Comparison

MOMO vs GERN Comparison

Compare MOMO & GERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hello Group Inc.

MOMO

Hello Group Inc.

HOLD

Current Price

$5.93

Market Cap

926.4M

Sector

Technology

ML Signal

HOLD

Logo Geron Corporation

GERN

Geron Corporation

HOLD

Current Price

$1.26

Market Cap

808.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MOMO
GERN
Founded
2011
1990
Country
China
United States
Employees
N/A
258
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
926.4M
808.3M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
MOMO
GERN
Price
$5.93
$1.26
Analyst Decision
Hold
Analyst Count
0
3
Target Price
N/A
$2.17
AVG Volume (30 Days)
383.3K
13.9M
Earning Date
06-04-2026
05-06-2026
Dividend Yield
4.61%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$26.91
Revenue Next Year
$3.68
$43.75
P/E Ratio
$10.60
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.69
$1.04
52 Week High
$9.22
$2.01

Technical Indicators

Market Signals
Indicator
MOMO
GERN
Relative Strength Index (RSI) 41.26 34.40
Support Level $5.69 $1.22
Resistance Level $6.52 $1.29
Average True Range (ATR) 0.14 0.06
MACD -0.03 -0.00
Stochastic Oscillator 24.24 21.15

Price Performance

Historical Comparison
MOMO
GERN

About MOMO Hello Group Inc.

Hello Group Inc is a foremost player in Asia's online social networking space. Through Momo, Tantan and other properties within its product portfolio, It enable users to discover new relationships, expand their social connections and build meaningful interactions. Momo is a mobile application that connects people and facilitates social interactions based on location, interests and a variety of online recreational activities. Tantan, which it added to its family of applications through acquisition. Tantan is designed to help its users find and establish romantic connections as well as meet interesting people. The Group determined that it operated in three operating segments namely Momo, Tantan and QOOL. The majority of revenue comes from Chinese mainland as compare to Overseas.

About GERN Geron Corporation

Geron Corp is a biopharmaceutical company focused on blood cancers. Its telomerase inhibitor, RYTELO (imetelstat), is approved in the United States and European Union for certain adult patients with lower-risk myelodysplastic syndromes (LR-MDS) with transfusion-dependent anemia. RYTELO inhibits telomerase activity in malignant stem and progenitor cells, which may reduce abnormal cell proliferation while supporting the production of healthy cells. It is also conducting a Phase 3 trial of imetelstat in patients with JAK-inhibitor-refractory or relapsed myelofibrosis (R/R MF) and studies in other hematologic malignancies. The company operates as a single segment, being the development of therapeutic products for oncology.

Share on Social Networks: